Ten-year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders study
- PMID: 21464343
- PMCID: PMC3158489
- DOI: 10.1001/archgenpsychiatry.2011.37
Ten-year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders study
Abstract
Context: Borderline personality disorder (BPD) is traditionally considered chronic and intractable.
Objective: To compare the course of BPD's psychopathology and social function with that of other personality disorders and with major depressive disorder (MDD) over 10 years.
Design: A collaborative study of treatment-seeking, 18- to 45-year-old patients followed up with standardized, reliable, and repeated measures of diagnostic remission and relapse and of both global social functioning and subtypes of social functioning.
Setting: Nineteen clinical settings (hospital and outpatient) in 4 northeastern US cities.
Participants: Three study groups, including 175 patients with BPD, 312 with cluster C personality disorders, and 95 with MDD but no personality disorder.
Main outcome measures: The Diagnostic Interview for DSM-IV Personality Disorders and its follow-along version (the Diagnostic Interview for DSM-IV Personality Disorders-Follow-Along Version) were used to diagnose personality disorders and assess changes in them. The Structured Clinical Interview for DSM-IV Axis I Disorders and the Longitudinal Interval Follow-up Evaluation were used to diagnose MDD and assess changes in MDD and in social function.
Results: Eighty-five percent of patients with BPD remitted. Remission of BPD was slower than for MDD (P < .001) and minimally slower than for other personality disorders (P < .03). Twelve percent of patients with BPD relapsed, a rate less frequent and slower than for patients with MDD (P < .001) and other personality disorders (P = .008). All BPD criteria declined at similar rates. Social function scores showed severe impairment with only modest albeit statistically significant improvement; patients with BPD remained persistently more dysfunctional than the other 2 groups (P < .001). Reductions in criteria predicted subsequent improvements in DSM-IV Axis V Global Assessment of Functioning scores (P < .001).
Conclusions: The 10-year course of BPD is characterized by high rates of remission, low rates of relapse, and severe and persistent impairment in social functioning. These results inform expectations of patients, families, and clinicians and document the severe public health burden of this disorder.
Figures




Similar articles
-
Distinguishing bipolar II depression from major depressive disorder with comorbid borderline personality disorder: demographic, clinical, and family history differences.J Clin Psychiatry. 2013 Sep;74(9):880-6. doi: 10.4088/JCP.13m08428. J Clin Psychiatry. 2013. PMID: 24107761
-
Personality disorders predict relapse after remission from an episode of major depressive disorder: a 6-year prospective study.J Clin Psychiatry. 2010 Dec;71(12):1629-35. doi: 10.4088/JCP.08m04200gre. Epub 2010 Jun 15. J Clin Psychiatry. 2010. PMID: 20584514 Free PMC article.
-
Interactions of borderline personality disorder and mood disorders over 10 years.J Clin Psychiatry. 2014 Aug;75(8):829-34. doi: 10.4088/JCP.13m08972. J Clin Psychiatry. 2014. PMID: 25007118
-
The borderline diagnosis I: psychopathology, comorbidity, and personality structure.Biol Psychiatry. 2002 Jun 15;51(12):936-50. doi: 10.1016/s0006-3223(02)01324-0. Biol Psychiatry. 2002. PMID: 12062877 Review.
-
A Life Span Perspective on Borderline Personality Disorder.Curr Psychiatry Rep. 2019 Jun 4;21(7):51. doi: 10.1007/s11920-019-1040-1. Curr Psychiatry Rep. 2019. PMID: 31161404 Free PMC article. Review.
Cited by
-
Current state of the evidence on community treatments for people with complex emotional needs: a scoping review.BMC Psychiatry. 2022 Sep 5;22(1):589. doi: 10.1186/s12888-022-04171-z. BMC Psychiatry. 2022. PMID: 36064337 Free PMC article.
-
Impaired memory for cooperative interaction partners in borderline personality disorder.Borderline Personal Disord Emot Dysregul. 2020 Oct 1;7:22. doi: 10.1186/s40479-020-00137-3. eCollection 2020. Borderline Personal Disord Emot Dysregul. 2020. PMID: 33014377 Free PMC article.
-
INdividual Vocational and Educational Support Trial (INVEST) for young people with borderline personality disorder: study protocol for a randomised controlled trial.Trials. 2020 Jun 26;21(1):583. doi: 10.1186/s13063-020-04471-3. Trials. 2020. PMID: 32591007 Free PMC article.
-
Elevated Monoamine Oxidase-A Distribution Volume in Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms, Suicidality, and Cognition.Biol Psychiatry. 2016 Jan 15;79(2):117-26. doi: 10.1016/j.biopsych.2014.11.024. Epub 2014 Dec 16. Biol Psychiatry. 2016. PMID: 25698585 Free PMC article.
-
Prevalence and 10-Year Stability of Personality Disorders From Adolescence to Young Adulthood in a High-Risk Sample.Front Psychiatry. 2022 Mar 24;13:840678. doi: 10.3389/fpsyt.2022.840678. eCollection 2022. Front Psychiatry. 2022. PMID: 35401274 Free PMC article.
References
-
- Grilo CM, McGlashan TH, Oldham JM. Course and stability of personality disorders. J Pract Psychiatry Behav Health. 1998;1(4):61–75.
-
- Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry. 1970;126(7):983–987. - PubMed
-
- Gunderson JG, Shea MT, Skodol AE, McGlashan TH, Morey LC, Stout RL, Zanarini MC, Grilo CM, Oldham JM, Keller MB. The Collaborative Longitudinal Personality Disorders Study: development, aims, design, and sample characteristics. J Pers Disord. 2000;14(4):300–315. - PubMed
Publication types
MeSH terms
Grants and funding
- K05 MH001654/MH/NIMH NIH HHS/United States
- K23 MH080221/MH/NIMH NIH HHS/United States
- R01 MH 01654/MH/NIMH NIH HHS/United States
- R01 MH050838/MH/NIMH NIH HHS/United States
- K23 MH073708/MH/NIMH NIH HHS/United States
- R01 MH050837/MH/NIMH NIH HHS/United States
- R01 MH050850/MH/NIMH NIH HHS/United States
- R01MH50850/MH/NIMH NIH HHS/United States
- R01 MH050840/MH/NIMH NIH HHS/United States
- R01 MH050840-13/MH/NIMH NIH HHS/United States
- R01MH50840/MH/NIMH NIH HHS/United States
- R01 MH 69904/MH/NIMH NIH HHS/United States
- R01 MH050839/MH/NIMH NIH HHS/United States
- R01 MH 080221/MH/NIMH NIH HHS/United States
- R01MH50839/MH/NIMH NIH HHS/United States
- R01 MH 50838/MH/NIMH NIH HHS/United States
- K23 MH069904/MH/NIMH NIH HHS/United States
- R01 MH 50837/MH/NIMH NIH HHS/United States
- R01 MH 73708/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources